tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XENE Stock Latest News

Xenon Pharmaceuticals to Present at Key Investor Conferences
Company AnnouncementsXenon Pharmaceuticals to Present at Key Investor Conferences
10d ago
XENE
Xenon Pharmaceuticals’ Earnings Call Highlights Optimism and Progress
PremiumCompany Announcements
Xenon Pharmaceuticals’ Earnings Call Highlights Optimism and Progress
12d ago
XENE
Xenon Pharmaceuticals price target raised to $58 from $55 at RBC Capital
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $58 from $55 at RBC Capital
12d ago
XENE
Xenon Pharmaceuticals price target lowered to $44 from $48 at Wells Fargo
PremiumThe Fly
Xenon Pharmaceuticals price target lowered to $44 from $48 at Wells Fargo
12d ago
XENE
Xenon Pharmaceuticals: Promising Drug Pipeline and Market Potential Drive Buy Rating
PremiumRatings
Xenon Pharmaceuticals: Promising Drug Pipeline and Market Potential Drive Buy Rating
12d ago
XENE
Xenon Pharmaceuticals: Promising Pipeline and Upcoming Catalysts Drive Buy Rating
PremiumRatingsXenon Pharmaceuticals: Promising Pipeline and Upcoming Catalysts Drive Buy Rating
12d ago
XENE
Xenon Pharmaceuticals Reports Q3 2025 Financial Results
Premium
Company Announcements
Xenon Pharmaceuticals Reports Q3 2025 Financial Results
13d ago
XENE
Xenon Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
Premium
Ratings
Xenon Pharmaceuticals: Promising Pipeline and Strong Financial Position Justify Buy Rating
13d ago
XENE
Xenon Reports Q3 2025 Financial Results and Progress
PremiumCompany Announcements
Xenon Reports Q3 2025 Financial Results and Progress
13d ago
8K
XENE
Xenon Pharmaceuticals reports Q3 EPS ($1.15), consensus ($1.16)
PremiumThe Fly
Xenon Pharmaceuticals reports Q3 EPS ($1.15), consensus ($1.16)
13d ago
XENE
XENE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
XENE Upcoming Earnings Report: What to Expect?
15d ago
XENE
Xenon Pharmaceuticals’ Phase 3 Study on Azetukalner: A Potential Game-Changer for Major Depressive Disorder
PremiumCompany Announcements
Xenon Pharmaceuticals’ Phase 3 Study on Azetukalner: A Potential Game-Changer for Major Depressive Disorder
20d ago
XENE
Xenon Pharmaceuticals’ Phase 3 Study on Azetukalner: A Potential Game-Changer in Depression Treatment
PremiumCompany AnnouncementsXenon Pharmaceuticals’ Phase 3 Study on Azetukalner: A Potential Game-Changer in Depression Treatment
20d ago
XENE
Xenon Pharmaceuticals’ XEN1101 Trial: A Promising Step in Seizure Treatment
Premium
Company Announcements
Xenon Pharmaceuticals’ XEN1101 Trial: A Promising Step in Seizure Treatment
20d ago
XENE
Xenon Pharmaceuticals Advances Bipolar Depression Treatment with Azetukalner Study
Premium
Company Announcements
Xenon Pharmaceuticals Advances Bipolar Depression Treatment with Azetukalner Study
20d ago
XENE
Xenon Pharmaceuticals’ Phase 3 Study on Azetukalner: A Potential Game-Changer in Bipolar Depression Treatment
PremiumCompany Announcements
Xenon Pharmaceuticals’ Phase 3 Study on Azetukalner: A Potential Game-Changer in Bipolar Depression Treatment
20d ago
XENE
Xenon Pharmaceuticals’ XEN1101: A Promising Epilepsy Treatment in the Making
PremiumCompany Announcements
Xenon Pharmaceuticals’ XEN1101: A Promising Epilepsy Treatment in the Making
20d ago
XENE
Xenon Pharmaceuticals’ Phase 3 Study on XEN1101: A Potential Game-Changer in Seizure Treatment
PremiumCompany Announcements
Xenon Pharmaceuticals’ Phase 3 Study on XEN1101: A Potential Game-Changer in Seizure Treatment
20d ago
XENE
Xenon Pharmaceuticals Advances MDD Treatment with Azetukalner Study
PremiumCompany Announcements
Xenon Pharmaceuticals Advances MDD Treatment with Azetukalner Study
20d ago
XENE
Xenon Pharmaceuticals to Announce Q3 2025 Financial Results
PremiumCompany AnnouncementsXenon Pharmaceuticals to Announce Q3 2025 Financial Results
20d ago
XENE
Xenon Pharmaceuticals Appoints Tucker Kelly as CFO to Drive Commercialization Efforts
Premium
Company Announcements
Xenon Pharmaceuticals Appoints Tucker Kelly as CFO to Drive Commercialization Efforts
1M ago
XENE
Xenon Pharmaceuticals appoints Tucker Kelly as Chief Financial Officer
Premium
The Fly
Xenon Pharmaceuticals appoints Tucker Kelly as Chief Financial Officer
1M ago
XENE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >